Navigation Links
Some antipsychotic drugs may be missing their mark
Date:12/31/2007

COLUMBUS, Ohio Drugs that treat depression, schizophrenia and other psychotic conditions and that target a particular protein on brain cells might not be triggering the most appropriate response in those cells, new research suggests.

The study by researchers at The Ohio State University Medical Center examined the serotonin 2A receptor, a protein on brain cells sensitive to the neurotransmitter serotonin.

This study examined the early chemical events that happen inside neurons when the 2A receptor is stimulated by serotonin and by a synthetic hallucinogenic agent that is thought to mimic serotonin.

The findings, published online in the early edition of the Proceedings of the National Academy of Sciences with an accompanying editorial, show that although both compounds combine with and activate this receptor, they trigger different chemical pathways inside the neuron.

Researchers say that the work could have important implications for the development of drugs that affect the serotonin 2A receptor, a key target in the treatment of several important mental disorders.

This new insight into how serotonin and a hallucinogenic drug affect this serotonin receptor could lead to changes in how new drugs are screened and developed for depression, schizophrenia and other neuropsychiatric disorders, says study leader Laura M. Bohn, an associate professor of pharmacology and psychiatry.

Currently, it is thought that when serotonin binds with the receptor, it sends a signal that activates molecules inside the cell called G proteins.

This study shows, however, that the receptor responds to serotonin by also activating a protein called beta-arrestin inside the cell. The synthetic hallucinogen, on the other hand, causes the receptor to activate only the G proteins. The hallucinogen does not seem to use beta-arrestins to cause its effects.

For this study, Bohn and her colleagues used laboratory-grown cells and a strain of mice that lacked beta
'/>"/>

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Antidepressant as Good as Antipsychotics for Dementia
3. New review suggests caution on drugs to raise good cholesterol
4. Can cancer drugs combine forces?
5. Study provides hope that some transplant patients could live free of antirejection drugs
6. Study provides hope that some transplant patients could live free of anti-rejection drugs
7. RA Drugs Linked to Slight Skin Cancer Risk
8. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
9. Rock N Roll: Sex, Drugs and an Early Exit
10. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 AquaPrint Solutions in Thomson, IL is ... with a newly-designed Harley Davidson motorcycle gas tank. A couple ... with an idea of taking a split tank motorcycle that ... transforming it into a work of art. , In ... several toilet seats that had been dipped in a water ...
(Date:6/19/2013)... Chicago is cracking down on bed bugs. New ... will require landlords to exterminate any and all reported bed ... ordinance also makes tenants responsible for reporting signs of bed ... often include disposing of furniture, bedding, and more. , In ... did more bed bug business in Chicago than any other ...
(Date:6/19/2013)... Orlando, FL (PRWEB) June 19, 2013 Fit ... and Andrea Laing recently held a charity boot camp in ... cystic fibrosis. The fitness boot camp franchise hosted ... a.m. to 11 a.m. with 75 boot camp participants and ... June charity boot camp marks the second fundraiser held for ...
(Date:6/19/2013)... June 19, 2013 The Cancer Support ... promise of cancer care for the whole patient with ... the Cancer Support Community. This inaugural event, held at ... Emanuel, MD., Ph.D., recognition of Congress members who have ... voices of patients and families currently engaged in the ...
(Date:6/19/2013)... UT (PRWEB) June 19, 2013 Ethigen ... BRCA1 and BRCA2 testing service , providing next-generation sequencing ... available individually, or as part of an expanded hereditary ... additional genes with known links to cancer risk: MLH1, ... SMAD4, BMPR1A, CDH1, MET, FH, FLCN, PDGFRA, and KIT. ...
Breaking Medicine News(10 mins):Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3
... disease, study shows, , WEDNESDAY, Sept. 16 (HealthDay News) ... women take to relieve menopausal symptoms seem to determine ... new French study suggests. , Overall, starting estrogen-progestagen ... of breast cancer, even when only used for short ...
... , GREENWOOD VILLAGE, Colo., Sept. ... cycle solutions for the healthcare industry, announced today that ... for Information Exchange (CORE(R)) Phase I Vendor Product Certification ... successfully completed certification testing - a process ensuring that ...
... NEW YORK, Sept. 16 Elderplan, a not-for-profit ... imaging services to its nearly 16,000 members through an exclusive ... management (RBM) company. , , In announcing ... Planning and Development, said "Elderplan members referred to diagnostic imaging ...
... RESEARCH TRIANGLE PARK, N.C., Sept. 16 GlaxoSmithKline (NYSE: ... to obtain for patients who are unemployed, uninsured or struggling to ... access to its patient assistance program, Bridges to Access, by offering ... or enrollment by telephone with the help of a healthcare advocate ...
... Presented by Food & Wine and Travel + Leisure Magazines ... , , NEW YORK, Sept. 16 Food ... Lee Schrager is pleased to announce that participating chefs of this year,s ... initiative with Weight Watchers. This is part of Weight Watchers second ...
... HARRISBURG, Pa., Sept. 16 Capital BlueCross announced today that ... vaccine for fully-insured members and those with individual coverage during ... have their coverage customized to include this benefit. , ... to the public in October. Various clinical vaccine trials have ...
Cached Medicine News:Health News:Timing, Type of HRT May Determine Breast Cancer Risk 2Health News:Timing, Type of HRT May Determine Breast Cancer Risk 3Health News:Recondo Technology Receives Certification From CAQH/Committee on Operating Rules for Information Exchange (CORE) 2Health News:Recondo Technology Receives Certification From CAQH/Committee on Operating Rules for Information Exchange (CORE) 3Health News:Elderplan Opts for Care to Care's Radiology Network 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 3Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 2Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 3Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 4Health News:Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2
(Date:6/19/2013)... ZIONA, Israel , June 19, 2013 ... results from a phase I study in volunteers, and ... Parkinson,s patients, of ND0612, were presented at the 2013 ... is a proprietary levodopa/carbidopa liquid drug formula under development ... that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... 19, 2013   Life Technologies Corporation ... agreement granting Suzhou Ribo Life Sciences (Ribo) the ... in China using Life,s ... siRNA molecules in combination with Invivofectamine® Rx to ... diseases with high unmet medical need in the ...
(Date:6/19/2013)... Juni 2013 Specialty Coating ... Entwicklung von SCS microRESIST™, einer antimikrobiellen ... Beschichtung mit Parylene gelungen ist. SCS ... Parylene mit antimikrobiellen Eigenschaften und erlaubt ... auf beschichteten medizinischen Geräten. ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... THE WOODLANDS, Texas , Jan. 25 In response ... York Times article, " Radiation Offers New Cures and Ways to ... patients and the general public understand that the benefits received from radiation therapy ... disease with help from the US Oncology physician network, and their loved ones, ...
... , , , MOUNTAIN VIEW, Calif. ... enrollment of its pivotal US study for the ArterX Vascular ... patients who were scheduled to receive a synthetic vascular graft ... applications involved the placement of arteriovenous dialysis access grafts, carotid ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2